Recombinant Bevacizumab 抗体
MALS verified
适用: 人
宿主: 小鼠
Monoclonal
AY10
unconjugated
Recombinant Antibody
-
- 抗原 See all Bevacizumab products
- Bevacizumab
- 抗体类型
- Recombinant Antibody
- 适用
- 人
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This Bevacizumab antibody is un-conjugated
- 原理
- Anti-Bevacizumab Antibody (AY10) (MALS verified, recommended for PK/PD)
- 产品特性
- Anti-idiotypic Antibodies
- 质量等级
- MALS verified
- 免疫原
- Mouse monoclonal antibody is produced from a hybridoma resulting from fusion of SP2/0 myeloma and B-lymphocytes obtained from a mouse immunized with Bevacizumab F(ab')2.
- 克隆位点
- AY10
-
-
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 储存条件
- -20 °C
-
- 抗原
- Bevacizumab
- Abstract
- Bevacizumab 产品
- 物质类
- Antibody
- 背景
- A recombinant humanized monoclonal IgG1 antibody that binds to and inhibits the biologic activity of human vascular endothelial growth factor (VEGF). Bevacizumab contains human framework regions and the complementarity-determining regions of a murine antibody that binds to VEGF. Bevacizumab is produced in a Chinese Hamster Ovary mammalian cell expression system in a nutrient medium containing the antibiotic gentamicin and has a molecular weight of approximately 149 kilodaltons.
-
You are here:
